Immune Monitoring to Facilitate Belatacept Monotherapy
Clinical trial NCT04177095 · COMPLETED
Trial details
- NCT number
- NCT04177095
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2021-09-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.